By Bhanvi Satija, Michael Erman (Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, ...

U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its heart ...

Pfizer has taken a $1.2 billion hit after reassessing the prospects of two antibody-drug conjugates (ADC) it picked up in the ...

Pfizer reported better than expected quarterly profits Tuesday behind cost cuts and growth in some non Covid related products including ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance, taking steps ...

Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...

Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

This update provides insights into critical global health developments, including Merck's halt on Gardasil shipments to China ...